Taro Pharmaceutical Industries Ltd TAL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TAL is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- ILS 39.60
- Day Range
- ILS 39.40–39.40
- 52-Week Range
- ILS 21.00–—
- Bid/Ask
- ILS 0.00 / ILS 0.00
- Market Cap
- ILS 1.48 Bil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- 34.08
- Price/Sales
- 2.64
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,554
- Website
- https://www.taro.com
Comparables
Valuation
|
Metric
|
TAL
|
000739
|
524742
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.08 | 15.75 | 23.35 |
Price/Book Value | 0.92 | 2.54 | 4.92 |
Price/Sales | 2.64 | 1.40 | 6.30 |
Price/Cash Flow | 21.01 | 14.95 | 26.58 |
Price/Earnings
TAL
000739
524742
Financial Strength
|
Metric
|
TAL
|
000739
|
524742
|
|---|---|---|---|
Quick Ratio | 3.03 | — | 4.03 |
Current Ratio | 3.60 | — | 5.67 |
Interest Coverage | — | — | 631.76 |
Quick Ratio
TAL
000739
524742
Profitability
|
Metric
|
TAL
|
000739
|
524742
|
|---|---|---|---|
Return on Assets (Normalized) | 2.15% | 8.04% | — |
Return on Equity (Normalized) | 2.62% | 17.08% | — |
Return on Invested Capital (Normalized) | 0.92% | 13.90% | — |
Return on Assets
TAL
000739
524742
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zlgtxldzls | Jncm | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Kfqhpxqsng | Sqfjw | $70.8 Bil | |
HLN
| Haleon PLC ADR | Lxvhtcg | Mnwbt | $38.2 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zwjwyggb | Ytdr | $14.6 Bil | |
VTRS
| Viatris Inc | Wzwykfdp | Nyrm | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ttqdmgk | Bshs | $12.6 Bil | |
CTLT
| Catalent Inc | Dthrjchz | Zxgfx | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Glvrgmnz | Tfjgm | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Hypzylygq | Sywc | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bprhsfrq | Hsvndl | $3.6 Bil |